Cargando…
Introducing personalised risk based intervals in screening for diabetic retinopathy: development, implementation and assessment of safety, cost-effectiveness and patient experience (ISDR): a case study in the use of automated systems in trials
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658818/ http://dx.doi.org/10.1186/1745-6215-16-S2-O59 |
| _version_ | 1782402576074932224 |
|---|---|
| author | Appelbe, Duncan Broadbent, Deborah Mobayen-Rahni, Mehrdad Eleuteri, Antonio Bennett, Abigail Moitt, Tracy Wang, Amu García-Fiñana, Marta Fisher, Anthony Harding, Simon |
| author_facet | Appelbe, Duncan Broadbent, Deborah Mobayen-Rahni, Mehrdad Eleuteri, Antonio Bennett, Abigail Moitt, Tracy Wang, Amu García-Fiñana, Marta Fisher, Anthony Harding, Simon |
| author_sort | Appelbe, Duncan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4658818 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46588182015-11-30 Introducing personalised risk based intervals in screening for diabetic retinopathy: development, implementation and assessment of safety, cost-effectiveness and patient experience (ISDR): a case study in the use of automated systems in trials Appelbe, Duncan Broadbent, Deborah Mobayen-Rahni, Mehrdad Eleuteri, Antonio Bennett, Abigail Moitt, Tracy Wang, Amu García-Fiñana, Marta Fisher, Anthony Harding, Simon Trials Oral Presentation BioMed Central 2015-11-16 /pmc/articles/PMC4658818/ http://dx.doi.org/10.1186/1745-6215-16-S2-O59 Text en Copyright © 2015 Appelbe et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Oral Presentation Appelbe, Duncan Broadbent, Deborah Mobayen-Rahni, Mehrdad Eleuteri, Antonio Bennett, Abigail Moitt, Tracy Wang, Amu García-Fiñana, Marta Fisher, Anthony Harding, Simon Introducing personalised risk based intervals in screening for diabetic retinopathy: development, implementation and assessment of safety, cost-effectiveness and patient experience (ISDR): a case study in the use of automated systems in trials |
| title | Introducing personalised risk based intervals in screening for diabetic retinopathy: development, implementation and assessment of safety, cost-effectiveness and patient experience (ISDR): a case study in the use of automated systems in trials |
| title_full | Introducing personalised risk based intervals in screening for diabetic retinopathy: development, implementation and assessment of safety, cost-effectiveness and patient experience (ISDR): a case study in the use of automated systems in trials |
| title_fullStr | Introducing personalised risk based intervals in screening for diabetic retinopathy: development, implementation and assessment of safety, cost-effectiveness and patient experience (ISDR): a case study in the use of automated systems in trials |
| title_full_unstemmed | Introducing personalised risk based intervals in screening for diabetic retinopathy: development, implementation and assessment of safety, cost-effectiveness and patient experience (ISDR): a case study in the use of automated systems in trials |
| title_short | Introducing personalised risk based intervals in screening for diabetic retinopathy: development, implementation and assessment of safety, cost-effectiveness and patient experience (ISDR): a case study in the use of automated systems in trials |
| title_sort | introducing personalised risk based intervals in screening for diabetic retinopathy: development, implementation and assessment of safety, cost-effectiveness and patient experience (isdr): a case study in the use of automated systems in trials |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658818/ http://dx.doi.org/10.1186/1745-6215-16-S2-O59 |
| work_keys_str_mv | AT appelbeduncan introducingpersonalisedriskbasedintervalsinscreeningfordiabeticretinopathydevelopmentimplementationandassessmentofsafetycosteffectivenessandpatientexperienceisdracasestudyintheuseofautomatedsystemsintrials AT broadbentdeborah introducingpersonalisedriskbasedintervalsinscreeningfordiabeticretinopathydevelopmentimplementationandassessmentofsafetycosteffectivenessandpatientexperienceisdracasestudyintheuseofautomatedsystemsintrials AT mobayenrahnimehrdad introducingpersonalisedriskbasedintervalsinscreeningfordiabeticretinopathydevelopmentimplementationandassessmentofsafetycosteffectivenessandpatientexperienceisdracasestudyintheuseofautomatedsystemsintrials AT eleuteriantonio introducingpersonalisedriskbasedintervalsinscreeningfordiabeticretinopathydevelopmentimplementationandassessmentofsafetycosteffectivenessandpatientexperienceisdracasestudyintheuseofautomatedsystemsintrials AT bennettabigail introducingpersonalisedriskbasedintervalsinscreeningfordiabeticretinopathydevelopmentimplementationandassessmentofsafetycosteffectivenessandpatientexperienceisdracasestudyintheuseofautomatedsystemsintrials AT moitttracy introducingpersonalisedriskbasedintervalsinscreeningfordiabeticretinopathydevelopmentimplementationandassessmentofsafetycosteffectivenessandpatientexperienceisdracasestudyintheuseofautomatedsystemsintrials AT wangamu introducingpersonalisedriskbasedintervalsinscreeningfordiabeticretinopathydevelopmentimplementationandassessmentofsafetycosteffectivenessandpatientexperienceisdracasestudyintheuseofautomatedsystemsintrials AT garciafinanamarta introducingpersonalisedriskbasedintervalsinscreeningfordiabeticretinopathydevelopmentimplementationandassessmentofsafetycosteffectivenessandpatientexperienceisdracasestudyintheuseofautomatedsystemsintrials AT fisheranthony introducingpersonalisedriskbasedintervalsinscreeningfordiabeticretinopathydevelopmentimplementationandassessmentofsafetycosteffectivenessandpatientexperienceisdracasestudyintheuseofautomatedsystemsintrials AT hardingsimon introducingpersonalisedriskbasedintervalsinscreeningfordiabeticretinopathydevelopmentimplementationandassessmentofsafetycosteffectivenessandpatientexperienceisdracasestudyintheuseofautomatedsystemsintrials |